Anupam Rasayan completes Bliss GVS Pharma takeover, holding 50.07% with its PAC

What happened

• On 28 September Anupam Rasayan bought 22,50,000 Bliss GVS Pharma shares, about 2.12% of the company, at ₹723.2883 each, for ₹162.74 crore, its filing says.
• With the shares bought earlier, Anupam Rasayan and Mates Visa Consultancy, which is acting in concert with it, hold 5,32,36,264 shares, or 50.07%. The filing gives 28 September 2026 as the date control was acquired.
• The share purchase agreement was signed on 23 May 2026 and the open offer shares were credited on 24 August, the filing says.
• HDFC Sky reported a total cost of ₹1,750 crore including ₹50 crore of expenses, paid for with a ₹300 crore term loan and about ₹1,450 crore raised through non-voting instruments from investors including Bain Capital, Trust Group and Investec.
• Bliss GVS, founded in 1984, sells more than 150 formulation brands and runs six plants in Maharashtra at about 30% capacity, the company said in its press release.

Why it matters

The deal takes the specialty chemicals maker into finished drug formulations. It described the purchase as its third step towards a pharma platform.

Good to know: A person acting in concert is someone who works with the buyer towards the same acquisition, so their shares are counted together with the buyer's when a company changes hands.

Key facts

Bought on 28 Sep

22,50,000 shares (~2.12%)

Price per share

₹723.2883

Combined holding

50.07%

Read the source

• Anupam Rasayan: acquisition of equity shares of Bliss GVS Pharma (filing, 29 Sep)NSE corporate announcements
• Anupam Rasayan concludes acquisition of Bliss GVS Pharma (press release)NSE corporate announcements
• Anupam Rasayan completes purchase of 48.2% stake in Bliss GVS Pharma for Rs 1,750 crHDFC Sky